文献速递神经肿瘤

内镜经蝶垂体腺瘤术后30天再入院分析:584例连续病例

Readmission after endoscopic transsphenoidal pituitary surgery: analysis of 584 consecutive cases.
PubMed 文献 · J Neurosurg · 2019-09-27

该研究基于单中心前瞻性数据库,分析2005—2018年584例内镜经鼻蝶垂体腺瘤手术患者,30天非计划再入院率为4.6%(27例),再入院平均时间6.6±3.9天,59%因迟发性低钠血症。再入院者术后住院时间更短、BMI更低。

要点

  • 内镜经蝶垂体腺瘤术后30天再入院率4.6%,多发生在术后第一周。
  • 迟发性低钠血症是再入院首要原因(59%),就诊时平均血钠120.6±4.6 mEq/L。
  • 术后住院时间短和BMI低与30天再入院相关。

核心结论

  • 内镜经蝶垂体腺瘤术后再入院相对少见,迟发性低钠血症是首要原因。
  • 术后住院时间较短和BMI较低与30天再入院相关。

研究设计与样本

  • 单中心前瞻性数据库分析,纳入2005—2018年NewYork-Presbyterian Hospital/Weill Cornell Medicine的584例内镜经鼻蝶垂体腺瘤手术患者。
  • 比较30天内非计划再入院病例与未再入院对照组的临床、社会经济和影像学资料。
  • 分类变量采用Pearson卡方检验和Fisher精确检验,连续变量采用独立样本t检验,α<0.05。

主要发现

  • 584例中27例(4.6%)发生30天内非计划再入院。
  • 再入院平均时间为6.6±3.9天,多数发生在术后第一周。
  • 59%的再入院原因为低钠血症,就诊时平均血钠120.6±4.6 mEq/L。
  • 其他再入院原因包括鼻出血(11%)、脊髓性头痛(11%)、鞍区血肿(7.4%)、脑脊液漏(3.7%)、非特异性头痛(3.7%)和肺栓塞(3.7%)。
  • 再入院者术后住院时间显著短于对照组(2.7±1.0天 vs 3.9±3.2天,p<0.05),因低钠血症再入院者初始住院时间最短(2.6±0.9天);再入院者平均BMI显著低于对照组(26.4±3.9 kg/m2 vs 29.3±6.1 kg/m2,p<0.05)。

临床怎么用

  • 对内镜经蝶垂体腺瘤术后患者,尤其术后住院时间短和BMI较低者,应警惕迟发性低钠血症并加强术后早期血钠监测。
  • 再入院多发生在术后第一周,出院后早期随访和患者教育应重点关注低钠血症相关症状。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hospital readmission is a key component in value-based healthcare models but there are limited data about the 30-day readmission rate after endonasal endoscopic transsphenoidal surgery (EETS) for pituitary adenoma. The objective of this study was to determine the incidence and identify factors associated with 30-day readmission after EETS for pituitary adenoma. METHODS: The authors analyzed a prospectively acquired database of patients who underwent EETS for pituitary adenoma from 2005 to 2018 at NewYork-Presbyterian Hospital, Weill Cornell Medicine. Clinical, socioeconomic, and radiographic data were reviewed for cases of unplanned readmission within 30 days of surgery and, as a control group, for all other patients in the series who were not readmitted. Statistical significance was determined with an alpha < 0.05 using Pearson's chi-square and Fisher's exact tests for categorical variables and the independent-samples t-test for continuous variables. RESULTS: Of 584 patients undergoing EETS for pituitary adenoma, 27 (4.6%) had unplanned readmission within 30 days. Most readmissions occurred within the first week after surgery, with a mean time to readmission of 6.6 ± 3.9 days. The majority of readmissions (59%) were for hyponatremia. These patients had a mean sodium level of 120.6 ± 4.6 mEq/L at presentation. Other causes of readmission were epistaxis (11%), spinal headache (11%), sellar hematoma (7.4%), CSF leak (3.7%), nonspecific headache (3.7%), and pulmonary embolism (3.7%). The postoperative length of stay was significantly shorter for patients who were readmitted than for the controls (2.7 ± 1.0 days vs 3.9 ± 3.2 days; p < 0.05). Patients readmitted for hyponatremia had an initial length of stay of 2.6 ± 0.9 days, the shortest of any cause for readmission. The mean BMI was significantly lower for readmitted patients than for the controls (26.4 ± 3.9 kg/m2 vs 29.3 ± 6.1 kg/m2; p < 0.05). CONCLUSIONS: Readmission after EETS for pituitary adenoma is a relatively rare phenomenon, with delayed hyponatremia being the primary cause. The study results demonstrate that shorter postoperative length of stay and lower BMI were associated with 30-day readmission.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Younus I, Gerges MM, Dobri GA, et al. Readmission after endoscopic transsphenoidal pituitary surgery: analysis of 584 consecutive cases. J Neurosurg. 2019. PMID: 31561225. doi:10.3171/2019.7.JNS191558

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。